These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Voon V; Hassan K; Zurowski M; Duff-Canning S; de Souza M; Fox S; Lang AE; Miyasaki J Neurology; 2006 Jun; 66(11):1750-2. PubMed ID: 16769956 [TBL] [Abstract][Full Text] [Related]
5. Iatrogenesis imperfecta. Friedman JH Med Health R I; 2002 Jul; 85(7):198. PubMed ID: 12182087 [No Abstract] [Full Text] [Related]
6. [Epidemiology of Parkinson disease]. Domínguez Carmona M An R Acad Nac Med (Madr); 1989; 106(2):175-220. PubMed ID: 2574955 [No Abstract] [Full Text] [Related]
8. [Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease]. Criado-Alvarez JJ; Romo-Barrientos C; Martínez-Hernández J; González-Solana I Rev Neurol; 1998 Sep; 27(157):405-8. PubMed ID: 9774809 [TBL] [Abstract][Full Text] [Related]
9. Punding prevalence in Parkinson's disease. Miyasaki JM; Al Hassan K; Lang AE; Voon V Mov Disord; 2007 Jun; 22(8):1179-81. PubMed ID: 17230464 [TBL] [Abstract][Full Text] [Related]
10. GSK's Requip slow the loss of dopamine function in Parkinson's disease. Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117 [No Abstract] [Full Text] [Related]
11. [Pharmacologic treatment in Parkinson disease]. García de Yébenes J; Fontán A; Rojo A Neurologia; 1999 May; 14 Suppl 1():17-33. PubMed ID: 10377727 [No Abstract] [Full Text] [Related]
14. [Treatments in the early stage of Parkinson disease]. Rascol O Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F77-84. PubMed ID: 18680822 [No Abstract] [Full Text] [Related]